ViewMind's Ocular Digital Phenotyping solution
is a holistic approach to brain and mental health that builds trust
through technology, enabling universal, language-free usage for
fast and accurate results.
SAN
ANTONIO, July 23, 2024 /PRNewswire/ -- Frost &
Sullivan recently analyzed the brain, mental, and neurological
diagnosis and treatment industry and, based on its results,
recognizes ViewMind with the 2024 North American Technology
Innovation Leadership Award. The company stands at the forefront of
precision brain health and neurology, offering easy-to-perform and
non-invasive assessments. Specializing in measuring ocular movement
alterations, the company provides a unique window into brain
health. Its digital assessments boast high sensitivity and
specificity, positioning it as a pivotal contributor to advancing
precision drug development and patient care. The company aims to
revolutionize central nervous system drug development and precision
patient care by providing scalable, affordable, and non-invasive
brain health markers. Its approach accurately assesses cognitive
domains and the health of associated brain regions, offering a
comprehensive view of neurocognitive health.
ViewMind's patented ocular digital phenotyping uses a
head-mounted display and sensors to track eye movements in response
to visual stimuli. It employs advanced statistical models to
analyze data, detecting even minor cognitive alterations or changes
in high-level motor function. The generated report provides
valuable insights into the patient's cognitive condition, enabling
physicians to make informed decisions. This innovative solution
combines advanced testing with a user-friendly experience and has
broad applications, such as helping pharmaceutical companies
pre-screen study participants and measure drug impacts, as well as
aiding healthcare institutions assess and monitor patients' brain
health and treatment effectiveness.
Deepali Sathe, senior industry
analyst at Frost & Sullivan, observed, "ViewMind is a
pioneering force in neuroscience and technology that is poised to
revolutionize brain and mental health diagnostics and drug
development.
With its transformative vision and dedication to
accuracy, ViewMind leads the way in brain and mental health
diagnostics and treatment."
ViewMind's technology is based on the fascinating connection
between eye movements and brain function. Although the eye is
primarily responsible for visual perception, it also plays a crucial
role in acquiring visual information. The eyes move precisely
through fixations and saccades to gather information that reveals
specific patterns in brain function. Understanding this has
significant implications for the diagnosis and comprehension of
neuropsychiatric and neurodegenerative disorders. The company
designed its test for controlled environments, typically a quiet
room, to ensure result accuracy. Training to administer the test is
straightforward and can be completed online in less than an hour.
The test is language-free and relies on shapes and eye movements,
making it universally applicable regardless of age, culture, or
educational background. The company's dedication to accuracy and
its forward-thinking approach make it a pivotal player in the
future of healthcare technology.
"ViewMind's innovative approach to measuring brain health stands
at the forefront of transformative advancements in brain and mental
health diagnosis and care. The company's commitment to precision
and accessibility through its digital assessments and non-invasive
technology aligns with this evolving landscape. ViewMind is poised
to lead the way in transforming brain and mental health diagnostics
and treatment by enabling improved
patient outcomes and revolutionizing brain
health assessment and care," said Natalia Casanovas,
best practices research analyst at Frost & Sullivan.
Each year, Frost & Sullivan presents this award to the
company that has developed a product with innovative features and
functionality that is gaining rapid acceptance in the market. The
award recognizes the quality of the solution and the customer value
enhancements it enables.
Frost & Sullivan Best Practices awards recognize companies
in various regional and global markets for demonstrating
outstanding achievement and superior performance in leadership,
technological innovation, customer service, and strategic product
development. Industry analysts compare market participants and
measure performance through in-depth interviews, analyses, and
extensive secondary research to identify best practices in the
industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned
for its role in helping investors, corporate leaders, and
governments navigate economic changes and identify disruptive
technologies, megatrends, new business models, and companies to
action, resulting in a continuous flow of growth opportunities to
drive future success. Contact us: Start the discussion. Contact us:
Start the discussion.
Contact:
Camila Tinajero
P: + 549 11 6713 2748
E: Camila.Tinajero@frost.com
About ViewMind
ViewMind is a global leader in precision measurement of ocular
movement alterations, a window into brain and mental health. With
high sensitivity and specificity, ViewMind's digital assessments
can contribute to advancing precision drug development and
precision patient care. For more information about ViewMind.
Contact:
Craig Davidson
Sermelo PR
P: +44 20 7240 6800
E: craig.davidson@sermelo.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viewmind-applauded-by-frost--sullivan-for-revolutionizing-brain-health-assessment-and-care-with-its-ocular-digital-phenotyping-solution-302201279.html
SOURCE Frost & Sullivan